🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to investigate the safety and activity in the ...
Status
Completed
Location
Arensia Clinical Research Unit
Start Date
2019-08-14
Trial ID
NCT04073498
A multicenter, randomized, double-blind, placebo-controlled phase III clini...
Status
Unknown
Location
Shanghai Sixth People's Hospital
Start Date
2019-06-30
Trial ID
NCT05060406
Treatments Being Tested
The aim of this study is to explore potential for reduction of incidence an...
Status
Completed
Location
Hospital General de Agudos Dr. Ignacio Pirovano
Start Date
2021-01-06
Trial ID
NCT04903184
Treatments Being Tested
To assess the clinical efficacy and safety of certolizumab pegol as add-on ...
Status
Completed
Location
Multiple Locations
Start Date
2008-06
Trial ID
NCT00674362
Treatments Being Tested
Human recombinant interleukin-2 (rhIL-2) is a biological signalling protein...
Status
Completed
Location
Service d'Endocrinologie Pédiatrique
Start Date
2013-06-27
Trial ID
NCT01862120
Treatments Being Tested
Liraglutide is a glucose-like peptide 1 agonist, currently used as an effec...
Status
Unknown
Location
Multiple Locations
Start Date
2020-04-01
Trial ID
NCT04008290
Treatments Being Tested
The purpose of this study is to evaluate the safety and immunogenicity of t...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-12-19
Trial ID
NCT02298179
Treatments Being Tested
This was a multi-center, multi-national, double-blind, randomized, comparat...
Status
Completed
Location
Multiple Locations
Start Date
2010-07-13
Trial ID
NCT01096849
Treatments Being Tested
The study is divided into 2 parts. In the first part, the safety of the gen...
Status
Completed
Location
University of California at San Diego Medical Center
Start Date
2007-03
Trial ID
NCT00454818
The purpose of the study is to investigate the mechanism of action for lige...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2020-08-05
Trial ID
NCT04513548
Treatments Being Tested